Cecily Quinn

5.7k total citations
128 papers, 2.8k citations indexed

About

Cecily Quinn is a scholar working on Cancer Research, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Cecily Quinn has authored 128 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Cancer Research, 69 papers in Pathology and Forensic Medicine and 54 papers in Oncology. Recurrent topics in Cecily Quinn's work include Breast Cancer Treatment Studies (76 papers), Breast Lesions and Carcinomas (67 papers) and Cancer and Skin Lesions (30 papers). Cecily Quinn is often cited by papers focused on Breast Cancer Treatment Studies (76 papers), Breast Lesions and Carcinomas (67 papers) and Cancer and Skin Lesions (30 papers). Cecily Quinn collaborates with scholars based in Ireland, United Kingdom and United States. Cecily Quinn's co-authors include Nicholas A. Wright, Arnold Hill, N. J. O’Higgins, Enda McDermott, Mary F. Dillon, Emad A. Rakha, Ann O’Doherty, A. O’Doherty, J.L. Ostrowski and E. McDermott and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Cecily Quinn

121 papers receiving 2.7k citations

Peers

Countries citing papers authored by Cecily Quinn

Since Specialization

Citations

This map shows the geographic impact of Cecily Quinn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cecily Quinn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cecily Quinn more than expected).

Fields of papers citing papers by Cecily Quinn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cecily Quinn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cecily Quinn. The network helps show where Cecily Quinn may publish in the future.

Co-authorship network of co-authors of Cecily Quinn

This figure shows the co-authorship network connecting the top 25 collaborators of Cecily Quinn. A scholar is included among the top collaborators of Cecily Quinn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cecily Quinn. Cecily Quinn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Calcification in breast histopathology 2025 ·Diagnostic histopathology ·(unknown), Aoife Maguire, Elena Provenzano, Cecily Quinn	0
2	Can we empirically derive a geographic definition of ‘coastal’ for use in cancer data reporting? An ecological modelling study using England’s national cancer registry 2024 ·SHILAP Revista de lepidopterología ·Claire Welsh, Clive Welham, Jack W. Anderson, Mark Green, Cecily Quinn, (unknown), Sally Vernon, Lizz Paley	1
3	A dedicated structured data set for reporting of invasive carcinoma of the breast in the setting of neoadjuvant therapy: recommendations from the International Collaboration on Cancer Reporting (ICCR) 2024 ·Histopathology ·Veerle Bossuyt, Elena Provenzano, W. Fraser Symmans, Fleur Webster, Kimberly H. Allison, Chau T. Dang, Helenice Gobbi, Janina Kulka, Sunil R. Lakhani, Takuya Moriya, Cecily Quinn, Anna Sapino, Stuart J. Schnitt, D.M. Sibbering, Elzbieta Slodkowska, Wentao Yang, Puay Hoon Tan, Ian O. Ellis	4
4	Dataset for reporting of the invasive carcinoma of the breast: recommendations from the International Collaboration on Cancer Reporting (ICCR) 2024 ·Histopathology ·Ian O. Ellis, Fleur Webster, Kimberly H. Allison, Chau T. Dang, Helenice Gobbi, Janina Kulka, Sunil R. Lakhani, Takuya Moriya, Cecily Quinn, Anna Sapino, Stuart J. Schnitt, D.M. Sibbering, Elzbieta Slodkowska, Wentao Yang, Puay Hoon Tan	3
5	Tumour 63 protein (p63) in breast pathology: biology, immunohistochemistry, diagnostic applications, and pitfalls 2023 ·Histopathology ·(unknown), (unknown), Cecily Quinn, Emad A. Rakha	2
6	Chromosome X aneusomy and androgen receptor gene copy number aberrations in apocrine carcinoma of the breast 2021 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Anna Laura Cremonini, Luca Saragoni, Luca Morandi, (unknown), (unknown), Enrico Di Oto, (unknown), Alejandro Martín Sánchez, (unknown), Riccardo Masetti, Cecily Quinn, Maria Pia Foschini	3
7	Atypia in breast pathology: what pathologists need to know 2021 ·Pathology ·Ayaka Katayama, Michael S. Toss, (unknown), Ian O. Ellis, Cecily Quinn, Emad A. Rakha	15
8	Real-world analysis of clinical and economic impact of 21-gene recurrence score (RS) testing in early-stage breast cancer (ESBC) in Ireland 2021 ·Breast Cancer Research and Treatment ·(unknown), (unknown), (unknown), (unknown), (unknown), Denis Evoy, James Geraghty, R S Prichard, Jane Rothwell, Damian McCartan, E. McDermott, Maccon Keane, Michael J. Kennedy, Séamus O’Reilly, (unknown), John Crown, Lillian M. Smyth, Catherine M. Kelly, Cecily Quinn, Janice M. Walshe	6
9	Nuclear morphology in breast lesions: refining its assessment to improve diagnostic concordance 2021 ·Histopathology ·Ayaka Katayama, Michael S. Toss, (unknown), Takaaki Sano, Tetsunari Oyama, Cecily Quinn, Ian O. Ellis, Emad A. Rakha	10
10	Retrospective observational study of HER2 immunohistochemistry in borderline breast cancer patients undergoing neoadjuvant therapy, with an emphasis on Group 2 (HER2/CEP17 ratio ≥2.0, HER2 copy number <4.0 signals/cell) cases 2021 ·British Journal of Cancer ·Emad A. Rakha, Islam M. Miligy, Cecily Quinn, Elena Provenzano, Abeer M. Shaaban, Caterina Marchiò, Michael S. Toss, (unknown), Ciara Murray, Janice M. Walshe, Ayaka Katayama, (unknown), (unknown), Bruce Tanchel, Rebecca Millican‐Slater, Colin A. Purdie, (unknown), Sarah E. Pinder, Ian O. Ellis, Andrew H.S. Lee	13
11	Metaplastic carcinomas of the breast without evidence of epithelial differentiation: a diagnostic approach for management 2020 ·Histopathology ·Emad A. Rakha, Cecily Quinn, Maria Pia Foschini, (unknown), David J. Dabbs, Sunil R. Lakhani, Zsuzsanna Varga, Sarah E. Pinder, Fernando Schmitt, Jorge S. Reis‐Filho, Stephen B. Fox, Ian O. Ellis, Puay‐Hoon Tan, (unknown)	14
12	False‐negative rate of ultrasound‐guided fine‐needle aspiration cytology for identifying axillary lymph node metastasis in breast cancer patients 2019 ·The Breast Journal ·(unknown), Christina Fleming, Helen Heneghan, Damian McCartan, Philip E. James, (unknown), Luke J. Harrington, (unknown), Cecily Quinn, Ann O’Doherty, (unknown), Jane Rothwell, Denis Evoy, James Geraghty, Enda McDermott, Ruth Prichard	24
13	Assessing the impact of the 2018 American Society of Clinical Oncology/College of American Pathologists recommendations on human epidermal growth factor receptor 2 testing by fluorescence in situ hybridization in breast carcinoma 2019 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Ciara Murray, Louise Flanagan, (unknown), Giuseppe Gullo, Cecily Quinn	8
14	Where youth matters—clinicopathologic characteristics and emerging trends in treatment and outcomes in young Irish women with breast cancer 2018 ·Irish Journal of Medical Science (1971 -) ·Megan Greally, (unknown), (unknown), (unknown), (unknown), (unknown), Niamh Coleman, Cecily Quinn, Enda McDermott, Giuseppe Gullo, John Crown, Ruth Prichard, Catherine M. Kelly, Janice M. Walshe	4
15	Comparison of Oncotype DX® Recurrence Score® with other risk assessment tools including the Nottingham Prognostic Index in the identification of patients with low-risk invasive breast cancer 2017 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Maura B. Cotter, (unknown), Aoife Maguire, Janice M. Walshe, Esther M. John, Barbara Dunne, (unknown), Cecily Quinn	4
16	New ASCO/CAP guideline recommendations for HER2 testing increase the proportion of reflex in situ hybridization tests and of HER2 positive breast cancers 2015 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Naïri Tchrakian, (unknown), Joe B. Harford, (unknown), Cecily Quinn	40
17	Axillary fine needle aspiration cytology for pre-operative staging of patients with screen-detected invasive breast carcinoma 2011 ·Journal of Clinical Pathology ·Brian Hayes, Linda Feeley, Cecily Quinn, (unknown), Ann O’Doherty, Fidelma Flanagan, (unknown)	13
18	Breast 10–21 2004 ·British journal of surgery ·Malcolm Kell, Daniel R. Lucey, Peter J. Holloway, M. Kennedy, (unknown), T. F. Gorey, T. P. Corrigan, Michael J. Kerin, Dara O. Kavanagh, Arnold Hill, (unknown), Cecily Quinn, Fergal J. Fleming, Alasdair F. O’Doherty, Chris Collins, E. McDermott, N. J. O’Higgins	0
19	Multisystem Langerhans' cell histiocytosis with pancreatic involvement. 1993 ·Gut ·Raymond C. Yu, (unknown), Cecily Quinn, Thomas Krausz, Anthony C. Chu	16
20	Pancreatic secretory trypsin inhibitor in gastrointestinal mucosa and gastric juice. 1990 ·Gut ·Tom C. Freeman, Raymond J. Playford, Cecily Quinn, K Beardshall, L W Poulter, (unknown), J Calam	37

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact